These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7193988)

  • 21. Does evidence of reductive halothane biotransformation correlate with hepatic binding of metabolites in obese patients?
    Bentley JB; Vaughan RW; Cork RC; Gandolfi AJ
    Anesth Analg; 1981 Aug; 60(8):548-51. PubMed ID: 7196167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metabolism of the volatile anesthetics (author's transl)].
    Yoshimura N
    Masui; 1977 Oct; 26(10):1100-12. PubMed ID: 21975
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of biotransformation in the toxicity of inhalation anesthetics.
    Vaughan RW; Sipes IG; Brown BR
    Life Sci; 1978 Dec; 23(25):2447-62. PubMed ID: 32456
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemical and biotransformation alterations in obesity.
    Vaughan RW
    Contemp Anesth Pract; 1982; 5():55-70. PubMed ID: 7053318
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of enzyme induction on nephrotoxicity of halothane-related compounds.
    Hitt BA; Mazze RI
    Environ Health Perspect; 1977 Dec; 21():179-83. PubMed ID: 612443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volatile anaesthetic metabolism and acute toxicity.
    Plummer JL; Cousins MJ; Hall P
    Q Rev Drug Metab Drug Interact; 1982; 4(1):49-98. PubMed ID: 6762625
    [No Abstract]   [Full Text] [Related]  

  • 27. Pulmonary biotransformation of methoxyflurane: an in-vitro study in the rabbit.
    Blitt CD; Brown BR; Wright BJ; Gandolfi AJ; Sipes IG
    Anesthesiology; 1979 Dec; 51(6):528-31. PubMed ID: 229743
    [No Abstract]   [Full Text] [Related]  

  • 28. Toxicity and biotransformation of volatile halogenated anesthetics in rat hepatocyte suspensions.
    DiRenzo AB; Gandolfi AJ; Brooks SD; Brendel K
    Drug Chem Toxicol; 1985; 8(4):207-18. PubMed ID: 4075996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of biotransformation in the toxicity of volatil anesthetics].
    Dauchot PJ; Cascorbi HF
    Anesth Analg (Paris); 1976; 33(5):723-5. PubMed ID: 1008280
    [No Abstract]   [Full Text] [Related]  

  • 30. Enflurane and methoxyflurane metabolism at anesthetic and at subanesthetic concentrations.
    White AE; Stevens WC; Eger EI; Mazze RI; Hitt BA
    Anesth Analg; 1979; 58(3):221-4. PubMed ID: 572159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxic metabolites from biotransformation: major organ damage.
    Van Dyke RA
    Int Anesthesiol Clin; 1981; 19(4):39-67. PubMed ID: 7309251
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the requirements for hepatic injury with halothane and enflurane in rats.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR
    Anesth Analg; 1985 Oct; 64(10):955-63. PubMed ID: 4037395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ and species differences in microsomal activation of methyldopa.
    Dybing E
    Drug Metab Dispos; 1976; 4(6):513-6. PubMed ID: 11971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of volatile anesthetics. 3. Induction of microsomal dechlorinating and ether-cleaving enzymes.
    Van Dyke RA
    J Pharmacol Exp Ther; 1966 Nov; 154(2):364-9. PubMed ID: 5922997
    [No Abstract]   [Full Text] [Related]  

  • 36. Halothane and enflurane metabolite elimination during anaesthesia in man.
    Imbenotte M; Erb F; Goldstein P; Erb C; Scherpereel P
    Eur J Anaesthesiol; 1987 May; 4(3):175-82. PubMed ID: 3595576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.
    Baker MT; Nelson RM; Van Dyke RA
    Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic inhalation of halothane, enflurane or isoflurane in rats.
    Plummer JL; Hall PM; Jenner MA; Ilsley AH; Cousins MJ
    Br J Anaesth; 1986 May; 58(5):517-23. PubMed ID: 3964517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents.
    Van Dyke RA; Gandolf AJ
    Drug Metab Dispos; 1976; 4(1):40-4. PubMed ID: 3400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicology of inhalation anesthetics and metabolites.
    Van Stee EW
    Annu Rev Pharmacol Toxicol; 1976; 16():67-79. PubMed ID: 7186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.